Characterization of Immune Responses Induced by Immunization with the HA DNA Vaccines of Two Antigenically Distinctive H5N1 HPAIV Isolates

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2012 Aug 4

PMID 22859976

Citations 3

Authors

Yulong Gao

Zhiyuan Wen

Ke Dong

Gongxun Zhong

Xiaomei Wang

Zhigao Bu

Hualan Chen

Ling Ye

Chinglai Yang

Affiliations

Soon will be listed here.

Abstract

The evolution of the H5N1 highly pathogenic avian influenza virus (HPAIV) has resulted in high sequence variations and diverse antigenic properties in circulating viral isolates. We investigated immune responses induced by HA DNA vaccines of two contemporary H5N1 HPAIV isolates, A/bar-headed goose/Qinghai/3/2005 (QH) and A/chicken/Shanxi/2/2006 (SX) respectively, against the homologous as well as the heterologous virus isolate for comparison. Characterization of antibody responses induced by immunization with QH-HA and SX-HA DNA vaccines showed that the two isolates are antigenically distinctive. Interestingly, after immunization with the QH-HA DNA vaccine, subsequent boosting with the SX-HA DNA vaccine significantly augmented antibody responses against the QH isolate but only induced low levels of antibody responses against the SX isolate. Conversely, after immunization with the SX-HA DNA vaccine, subsequent boosting with the QH-HA DNA vaccine significantly augmented antibody responses against the SX isolate but only induced low levels of antibody responses against the QH isolate. In contrast to the antibody responses, cross-reactive T cell responses are readily detected between these two isolates at similar levels. These results indicate the existence of original antigenic sin (OAS) between concurrently circulating H5N1 HPAIV strains, which may need to be taken into consideration in vaccine development against the potential H5N1 HPAIV pandemic.

Citing Articles

Impact of antigenic evolution and original antigenic sin on SARS-CoV-2 immunity.

Aguilar-Bretones M, Fouchier R, Koopmans M, van Nierop G J Clin Invest. 2023; 133(1).

PMID: 36594464 PMC: 9797340. DOI: 10.1172/JCI162192.

Humans and ferrets with prior H1N1 influenza virus infections do not exhibit evidence of original antigenic sin after infection or vaccination with the 2009 pandemic H1N1 influenza virus.

ODonnell C, Wright A, Vogel L, Boonnak K, Treanor J, Subbarao K Clin Vaccine Immunol. 2014; 21(5):737-46.

PMID: 24648486 PMC: 4018878. DOI: 10.1128/CVI.00790-13.

MDA5 can be exploited as efficacious genetic adjuvant for DNA vaccination against lethal H5N1 influenza virus infection in chickens.

Liniger M, Summerfield A, Ruggli N PLoS One. 2012; 7(12):e49952.

PMID: 23227156 PMC: 3515599. DOI: 10.1371/journal.pone.0049952.

References

Smith G, Vijaykrishna D, Bahl J, Lycett S, Worobey M, Pybus O . Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature. 2009; 459(7250):1122-5. DOI: 10.1038/nature08182. View

Wen Z, Ye L, Gao Y, Pan L, Dong K, Bu Z . Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge. Antiviral Res. 2009; 84(3):215-24. PMC: 2787645. DOI: 10.1016/j.antiviral.2009.09.005. View

HENNESSY A, DAVENPORT F, FRANCIS Jr T . Studies of antibodies to strains of influenza virus in persons of different ages in sera collected in a postepidemic period. J Immunol. 1955; 75(5):401-9. View

Kim J, Skountzou I, Compans R, Jacob J . Original antigenic sin responses to influenza viruses. J Immunol. 2009; 183(5):3294-301. PMC: 4460008. DOI: 10.4049/jimmunol.0900398. View

Sturm-Ramirez K, Ellis T, Bousfield B, Bissett L, Dyrting K, Rehg J . Reemerging H5N1 influenza viruses in Hong Kong in 2002 are highly pathogenic to ducks. J Virol. 2004; 78(9):4892-901. PMC: 387679. DOI: 10.1128/jvi.78.9.4892-4901.2004. View

DAVENPORT F, HENNESSY A . A serologic recapitulation of past experiences with influenza A; antibody response to monovalent vaccine. J Exp Med. 1956; 104(1):85-97. PMC: 2136633. DOI: 10.1084/jem.104.1.85. View

Wu W, Chen Y, Wang P, Song W, Lau S, Rayner J . Antigenic profile of avian H5N1 viruses in Asia from 2002 to 2007. J Virol. 2007; 82(4):1798-807. PMC: 2258718. DOI: 10.1128/JVI.02256-07. View

Valkenburg S, Rutigliano J, Ellebedy A, Doherty P, Thomas P, Kedzierska K . Immunity to seasonal and pandemic influenza A viruses. Microbes Infect. 2011; 13(5):489-501. PMC: 3549300. DOI: 10.1016/j.micinf.2011.01.007. View

Virelizier J, Postlethwaite R, Schild G, Allison A . Antibody responses to antigenic determinants of influenza virus hemagglutinin. I. Thymus dependence of antibody formation and thymus independence of immunological memory. J Exp Med. 1974; 140(6):1559-70. PMC: 2139740. DOI: 10.1084/jem.140.6.1559. View

10.

Kilbourne E . Influenza pandemics of the 20th century. Emerg Infect Dis. 2006; 12(1):9-14. PMC: 3291411. DOI: 10.3201/eid1201.051254. View

11.

Giles B, Bissel S, DeAlmeida D, Wiley C, Ross T . Antibody breadth and protective efficacy are increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin-based H5N1 virus-like particle vaccines. Clin Vaccine Immunol. 2011; 19(2):128-39. PMC: 3272934. DOI: 10.1128/CVI.05533-11. View

12.

Gao Y, Zhang Y, Shinya K, Deng G, Jiang Y, Li Z . Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host. PLoS Pathog. 2009; 5(12):e1000709. PMC: 2791199. DOI: 10.1371/journal.ppat.1000709. View

13.

Boon A, Webby R . Antigenic cross-reactivity among H5N1 viruses. Curr Top Microbiol Immunol. 2009; 333:25-40. DOI: 10.1007/978-3-540-92165-3_2. View

14.

Claas E, Osterhaus A, Van Beek R, de Jong J, Rimmelzwaan G, Senne D . Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet. 1998; 351(9101):472-7. DOI: 10.1016/S0140-6736(97)11212-0. View

15.

Wrammert J, Smith K, Miller J, Langley W, Kokko K, Larsen C . Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature. 2008; 453(7195):667-71. PMC: 2515609. DOI: 10.1038/nature06890. View

16.

Angelova L, Shvartsman YaS . Original antigenic sin to influenza in rats. Immunology. 1982; 46(1):183-8. PMC: 1555333. View

17.

Li Y, Shi J, Zhong G, Deng G, Tian G, Ge J . Continued evolution of H5N1 influenza viruses in wild birds, domestic poultry, and humans in China from 2004 to 2009. J Virol. 2010; 84(17):8389-97. PMC: 2919039. DOI: 10.1128/JVI.00413-10. View

18.

Echevarria-Zuno S, Mejia-Arangure J, Mar-Obeso A, Grajales-Muniz C, Robles-Perez E, Gonzalez-Leon M . Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet. 2009; 374(9707):2072-2079. DOI: 10.1016/S0140-6736(09)61638-X. View

19.

FRANCIS Jr T, DAVENPORT F, HENNESSY A . A serological recapitulation of human infection with different strains of influenza virus. Trans Assoc Am Physicians. 1953; 66:231-9. View

20.

Siengsanan J, Chaichoune K, Phonaknguen R, Sariya L, Prompiram P, Kocharin W . Comparison of outbreaks of H5N1 highly pathogenic avian influenza in wild birds and poultry in Thailand. J Wildl Dis. 2009; 45(3):740-7. DOI: 10.7589/0090-3558-45.3.740. View